$HLSQ 3 SEC Filings

Filed On	Filing
03 Mar 2026	Form 3: Bidas Liat Cohavi, Director No securities owned
16 Jan 2026	Form 3: Yeganeh Reuven, Director
15 Apr 2024	Form 3: Blum Susan, Director No securities owned
26 Mar 2024	Form 3: Cystic Fibrosis Foundation, 10% owner Holds 4,552,315 shares of Common Stock, par value $0.0001 per share
21 Mar 2024	Form 3: Leff Jonathan S, Director No securities owned
21 Mar 2024	Form 3: Merril Gregory Louis, Director No securities owned
21 Mar 2024	Form 3: Goodman Jesse, Director No securities owned
19 Mar 2024	Form 3: Flynn James E, Director and 5 others No securities owned
11 Dec 2023	Form 3: Gabay Avraham, Interim CFO No securities owned
18 Oct 2023	Form 3: Williams Eddie, Director No securities owned
19 May 2023	Form 3: Marks Jason M., Director No securities owned
19 May 2023	Form 3: Dambach Michael E., Director No securities owned
14 Feb 2022	Form 3: Ugwumba Chidozie, 10% owner Holds 3,637,846 shares of Common Stock
09 Aug 2021	Form 3: Walton Thomas Layton, 10% owner Holds 3,637,846 shares of Common Stock, $0.0001 par value
05 Oct 2020	Form 3: Sekhri Paul J, Director No securities owned
05 Oct 2020	Form 3: Moses Alan Charles, Director No securities owned
15 Jan 2020	Form 3: Wolfson Marina, Principal Financial Officer No securities owned
31 Dec 2019	Form 3: Propper Kerry, 10% owner and 1 other
12 Nov 2019	Form 3: Sullivan Lynne Marie, Director No securities owned
08 Nov 2019	Form 3: Ben-Or Uri, Director No securities owned

Comments